{"uniprot":"Q96A09","gene":"TENT5B","name":"Terminal nucleotidyltransferase 5B","organism":"Homo sapiens (Human)","status":"dark","length":425,"sequence":"MMPSESGAERRDRAAAQVGTAAATAVATAAPAGGGPDPEALSAFPGRHLSGLSWPQVKRLDALLSEPIPIHGRGNFPTLSVQPRQIVQVVRSTLEEQGLHVHSVRLHGSAASHVLHPESGLGYKDLDLVFRVDLRSEASFQLTKAVVLACLLDFLPAGVSRAKITPLTLKEAYVQKLVKVCTDSDRWSLISLSNKSGKNVELKFVDSVRRQFEFSIDSFQIILDSLLLFGQCSSTPMSEAFHPTVTGESLYGDFTEALEHLRHRVIATRSPEEIRGGGLLKYCHLLVRGFRPRPSTDVRALQRYMCSRFFIDFPDLVEQRRTLERYLEAHFGGADAARRYACLVTLHRVVNESTVCLMNHERRQTLDLIAALALQALAEQGPAATAALAWRPPGTDGVVPATVNYYVTPVQPLLAHAYPTWLPCN","function_summary":"A soluble human RNA-modifying enzyme that transfers nucleotidyl groups to mRNA 3′ ends and assembles with RNA-binding cofactors to enhance post-transcriptional control. By promoting adenylylation and tuning mRNA stability and engagement with the translation machinery, it boosts translational output in the cytoplasm while also participating in nuclear–cytoplasmic RNA pathways. This translational regulation shapes cell fate programs, dampening proliferation and cell-cycle progression yet reinforcing survival pathways and apoptosis resistance.","plain_language":"TENT5B has barely been studied. The model's best guess: A soluble human RNA-modifying enzyme that transfers nucleotidyl groups to mRNA 3′ ends and assembles with RNA-binding cofactors to enhance post-transcriptional control. By promoting adenylylation and tuning mRNA stability and engagement with the translation machinery, it boosts translational output in the cytoplasm while also participating in nuclear–cytoplasmic RNA pathways.","uniprot_summary":"Involved in post-transcriptional regulation of gene expression.","go_terms":{"molecular_function":[{"id":"GO:0004652","label":"polynucleotide adenylyltransferase activity"},{"id":"GO:0005515","label":"protein binding"}],"biological_process":[{"id":"GO:0010608","label":"post-transcriptional regulation of gene expression"},{"id":"GO:0045727","label":"positive regulation of translation"},{"id":"GO:0008285","label":"negative regulation of cell population proliferation"},{"id":"GO:0045786","label":"negative regulation of cell cycle"},{"id":"GO:0043066","label":"negative regulation of apoptotic process"}],"cellular_component":[{"id":"GO:0005737","label":"cytoplasm"},{"id":"GO:0005634","label":"nucleus"}]},"interpro":[{"id":"IPR012937","name":"Terminal nucleotidyltransferase","type":"family","start":45,"end":425}],"reasoning":"I begin with the domain architecture. The protein contains a single, centrally placed catalytic module, IPR012937 (Terminal nucleotidyltransferase family) spanning residues 45–425. This family defines the classical polymerase-like nucleotidyltransferase fold that catalyzes template-independent addition of nucleotides to the 3′ end of nucleic acids. The breadth of this domain across most of the polypeptide indicates that catalysis and RNA recognition are integrated within one continuous core rather than modularized. Such terminal nucleotidyltransferases typically bind RNA via basic patches and flexible loops flanking the active site and often operate in concert with RNA-binding partners. This architecture causes two molecular capabilities: a catalytic activity that transfers nucleotidyl groups to RNA termini and a propensity for multivalent protein binding that recruits regulatory cofactors.\n\nFrom this architecture, I infer molecular function. The terminal nucleotidyltransferase fold directly supports GO:0004652 polynucleotide adenylyltransferase activity, i.e., template-independent addition of AMP to RNA ends. The same fold and its extensive RNA/protein interfaces rationalize GO:0005515 protein binding, because stable assemblies with RNA-binding cofactors and translational machinery are required to position the RNA substrate and tune activity.\n\nThese molecular activities propagate into specific biological processes. By adenylating and potentially polyadenylating mRNA termini, the enzyme modulates mRNA stability and ribosome engagement, which drives GO:0010608 post-transcriptional regulation of gene expression. Enhanced ribosome loading and mRNA maturation causally lead to GO:0045727 positive regulation of translation. Increased translational output can restrain proliferation and cell-cycle progression under certain contexts—especially when coupled to selective mRNA cohorts—accounting for GO:0008285 negative regulation of cell population proliferation and GO:0045786 negative regulation of cell cycle. Conversely, by stabilizing transcripts that promote survival pathways, the same translational control axis can produce GO:0043066 negative regulation of apoptotic process. Thus, the enzymatic core and its RNA-centric interactions jointly explain the full set of process annotations.\n\nCellular location follows from function and binding requirements. The absence of transmembrane segments and the soluble catalytic core point to a non-membranous environment. Post-transcriptional control and translational enhancement typically occur in the cytoplasm, supporting GO:0005737 cytoplasm. However, many RNA-processing and mRNA-assembly steps initiate in the nucleus before export, and nucleotidyltransferase activities often shuttle with RNA substrates; this supports dual residency including GO:0005634 nucleus. The experimentally observed cytoplasmic localization aligns with the primary translational role, while nuclear presence is consistent with assembly and handoff of RNA-protein complexes.\n\nMechanistically, I hypothesize that the enzyme forms a ribonucleoprotein assembly that positions mRNA 3′ ends for adenylylation and coordinates with translation initiation factors. The catalytic core likely partners with cytoplasmic poly(A)-binding proteins and cap-binding complexes to stabilize and activate mRNAs. Through these assemblies, the enzyme enhances ribosome recruitment and mRNA lifespan, thereby tuning proliferation, cell-cycle checkpoints, apoptosis resistance, and overall translational capacity. I further hypothesize transient interactions with cytoplasmic mRNA-binding scaffolds and initiation factors that concentrate the enzyme at actively translated ribonucleoprotein granules and cytoplasmic RNA-processing hubs.","category":"dark","control_evaluation":null,"validation_plan":null,"structure":{"source":"AlphaFold DB","pdb":"/structures/AF-Q96A09.pdb","alphafold":"https://alphafold.ebi.ac.uk/entry/Q96A09"},"links":{"uniprot":"https://www.uniprot.org/uniprotkb/Q96A09/entry","atlas":"/p/Q96A09"},"provenance":{"model":"BioReason-Pro (ESM3 esm3-sm-open-v1)","source_list":"Pharos Tdark","note":"AI prediction, not experimentally verified"}}